FOR US RESIDENTS ONLY
Send Email  SEND TO A FRIEND   |   Print this page PRINT PAGE   |  A A A

CML Therapy Support For Patients and Caregivers

Novartis, the global leader in Ph+ CML therapy, has been working with healthcare professionals and patients worldwide for more than 5 years to improve the treatment of Ph+ CML.

Novartis introduces CML Alliance™, a unique support program designed to help optimize outcomes in Ph+ CML patients.

• Programs designed to help improve adherence to Ph+ CML therapy
• Access to reimbursement support

• Valuable educational information on living with Ph+ CML, including www.LivingWithCML.com

 

The more you know about treating Ph+ CML, the more you will be able to play an active role in your treatment.
Novartis Oncology is committed to supporting the care of eligible patients.
Information for Healthcare Professionals